Traditional Chinese medicine decoction for treating thrombocytopenia

Abstract

The invention discloses a traditional Chinese medicine decoction for treating thrombocytopenia. The traditional Chinese medicine decoction comprises the following raw materials in parts by weight: 5.5-6.5 parts of dried rehmannia root, 6-7 parts of astragalus root, 2-4 parts of glossy privet fruit, 6-8 parts of spatholobus stem, 2-4 parts of notoginseng, 1-3 parts of muskmelon skin, 6-8 parts of carbonized sanguisorba root, 4-6 parts of radix codonopsis pilosulae, 2-4 parts of black sesame seed, 4-6 parts of common dodder, 1-3 parts of giant knotweed rhizome, 6-8 parts of semen litchi, 2-4 parts of pteridium squilinum, 1-3 parts of rubia root, 5-7 parts of cortex lycii radicis, 3-5 parts of cordyceps sinensis, 2-4 parts of tuckahoe, 5-7 parts of rhizoma polygonati, 1-3 parts of purpleflower holly bark, 2-4 parts of doellingeria scaber root, 2-4 parts of clinopodium chinense, 1-3 parts of black soybean leaf and 4-6 parts of drymaria cordata. The Chinese medicinal composition disclosed by the invention has effects on clearing away heat and toxic materials, cooling blood to remove stasis, invigorating qi, nourishing Yin and tonifying the kidneys, is quick and effective in treating thrombocytopenia, high in cure rate and low in recurrence rate, does not have any toxic or side effects, and can improve human immunity and improve the physical quality of patients.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction for treating thrombocytopenia, which belongs to the field of traditional Chinese medicines. Background technique [0002] Idiopathic thrombocytopenic purpura, also known as idiopathic thrombocytopenic purpura or immune thrombocytopenic purpura, is an immune syndrome, referring to thrombocytopenia caused by no obvious exogenous etiology, treatment of essential thrombocytopenia Western medicines commonly used to hemostatic purpura, such as: intramuscular or intravenous injection of hemostatic sensitization, oral administration of blood, etc., can also use some antifibrinolytic drugs, such as: intravenous infusion of 6-aminocaproic acid, intravenous infusion of hemostatic aryl acid , oral administration of hemostatic scurvy, etc.; western medicine treatment can temporarily relieve symptoms, and may save critical illness, but the curative effect is unstable and easy to relapse; traditional C...

AI Technical Summary

Problems solved by technology

[0002] Idiopathic thrombocytopenic purpura, also known as idiopathic thrombocytopenic purpura or immune thrombocytopenic purpura, is an immune syndrome, referring to thrombocytopenia caused by no obvious exogenous etiology, treatment of essential thrombocytopenia Western medicines commonly used to hemostatic purpura, such as: intramuscular or intravenous injection of hemostatic sensitization, oral administration of blood, etc., can also use some antifibrinolytic drugs, such as: intravenous infusion of 6-aminocaproic acid, intravenous infusion of hemostatic aryl acid , oral administration of hemostatic scurvy, etc.; western medicine treatment can temporarily relieve symptoms, and may save critical illness, but the curative effect is unstable and easy to relapse; traditional Chinese medicine treatment: taking Banlangen Granules to prevent and deal with the attacking patients. There are also many targeted Chinese patent medicines, all of which are can receive a certain effect